Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil
P Wibault, M A Bensmaine, M de Forni, et al.
British Journal of Cancer
|
September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
X Pivot, E Raymond, B Laguerre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2011
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
J-C Soria, J Cortes, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
M Degardin, J Oliveira, L Geoffrois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study
C Oberhoff, B Neri, D Amadori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients
R De Crevoisier, J Bourhis, C Domenge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
J P Delord, E Raymond, M Chaouche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation
Ch Van Kesteren, R A A Mathôt, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
C A Gomez-Roca, L Lacroix, C Massard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J M Michot, C Bigenwald, S Champiat, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1996
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil
P Wibault, M A Bensmaine, M de Forni, et al.
British Journal of Cancer
|
September 5, 2001
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck
X Pivot, E Raymond, B Laguerre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2011
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors
J-C Soria, J Cortes, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
M Degardin, J Oliveira, L Geoffrois, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study
C Oberhoff, B Neri, D Amadori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients
R De Crevoisier, J Bourhis, C Domenge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
J P Delord, E Raymond, M Chaouche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 28, 2002
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation
Ch Van Kesteren, R A A Mathôt, E Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2011
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
C A Gomez-Roca, L Lacroix, C Massard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 15, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J M Michot, C Bigenwald, S Champiat, et al.
Page
of 15